NORWELL, Mass.--(BUSINESS WIRE)--Working at a desk all day and doing strenuous manual labor have at least one thing in common - they both can lead to back pain. Hocoma, a leader in the development of robotic and sensor-based medical devices for functional movement therapy, has released a special report addressing new options to decrease the costs and loss of productivity associated with employee low back pain (LBP).
The recently published report, titled “Sore Points: How Much is Employee Back Pain Costing Your Company?”, discusses a growing employer concern, the costs resulting from LBP in the workplace. Over 84% of the population will experience at least one episode of low back pain in their lifetime, and nearly one in four employees reported experiencing lower back pain in the past three months.[1, 2] Additional LBP facts detailed in the special report affecting the corporate bottom line, include:
- Annual cost of LBP to employers per 100 workers amounts to $34,600 
- Back pain is #1 cause for work related disability in U.S. 
- Employees with back pain are absent an average of 4 days more each year than those without back pain, a total costs in lost productivity of $13,100 per 100 workers annually. 
- Presenteeism, or the act of attending work while sick, related to back pain adds up to $8,300 per 100 workers annually 
“The epidemic of low back pain in the workplace takes a toll not just on the health and lives of workers but also on the companies and organizations for which they work,” said Frank Menzler, Executive Vice President of Hocoma Inc., “However, back pain is often both treatable and preventable. C-suite, human resource and corporate wellness executives can look to this special report to learn new options to alleviate the pain to their company’s bottom line. ”
This special report looks at the effects of back pain in the workplace, as well as some of the proactive steps employers can take to reduce LBP, including the implementation of gamification treatment to employee wellness programs. Hocoma’s Valedo, the first wearable medical device for the low back that combines physical sensors with sophisticated, yet intuitive software to motivate and guide users through fun and interactive exercises, offers a new gamification option for addressing non-specific employee low back pain.
This special report is a must read for anyone seeking to improve productivity and decrease costs associated with employee back pain. Download a complimentary copy of the special report, “Sore Points: How Much is Employee Back Pain Costing Your Company?”
Media images can be found at the Valedo Press Center.
A successful therapy begins in patients’ heads. In the firm belief that – step by step – they can reach their goals and regain quality of life.
This is what we work for at the Swiss medtech company Hocoma. With technologies and ideas that look at functional movement therapy from a completely different angle. Because they enable independent exercises and create maximum motivation. Because they challenge people to take courage and support their hopes with personal achievements.
We are committed to creating the ideal therapy. Our awarded robotic and sensor-based devices offer solutions for intensive gait therapy (Lokomat®), functional therapy of the upper extremities (Armeo®), robotic mobilization and functional electrical stimulation in early rehabilitation (Erigo®) as well as functional movement therapy within low back pain treatment (Valedo® Therapy Concept) at home and at the clinic. They are the result of intensive research, consistent development and continuous exchange with patients, therapists and partners in research and science.
Who wants to breaks new grounds has to stay open to exceptional ideas. They have the potential of being exceptionally effective. This guiding principle by Hocoma founder and CEO Dr. Gery Colombo has accompanied us since our start in the year 2000 and is still lived and implemented by our dedicated employees around the world. At the headquarters in Volketswil near Zurich (Switzerland) and the subsidiaries in the USA, Singapore and Slovenia they achieved a turnover of more than 30 million CHF in 2014.
All Hocoma products are medical devices and must be used in strict adherence to the User Manual; failure to do so may result in serious personal injury. It is strongly recommended that you regularly consult Hocoma’s website (www.hocoma.com/legalnotes) for the latest available information. Please contact Hocoma in case of any questions.
Use only under the supervision of qualified medical personnel. However, certain Hocoma products are marketed for home use and must be strictly used according to the recommendations of your medical care provider who is knowledgeable about your specific needs. Consult the User Manual and Hocoma’s website (www.hocoma.com/legalnotes) for appropriate product designation. Failure to obtain and follow the recommendations of your medical care provider may result in serious personal injury.
This information provides details about medical products which may not be available in all countries and may not have received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any specific use for any product which is not authorized by the laws and regulations of the country where the reader of this information resides.
References:  Bryla, Jacy. Low Back Pain Takes Toll on Worker Health & Productivity. Integrated Benefits Institute. October 23, 2013.  Airaksinen et al., 2006. European Guidelines for the Management of Chronic Non-specific Low Back Pain. Eur Spine J. 2006 Mar;15 Suppl 2:S192-300.